TREATING BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN DEMENTIA PATIENTS

The present invention provides a method for treating behavioral and psychological symptoms in patient with dementia comprising administering an effective dose of pure 5-HT6 receptor antagonist, masupirdine or a pharmaceutically acceptable salt thereof either alone or in combination with an acetylcho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NIROGI Ramakrishna, MOHAMMED Abdul Rasheed, PANDEY Santosh Kumar, JETTA Satish, SHINDE Anil Karbhari, JASTI Venkateswarlu, PALACHARLA Raghava Chowdary, RAVULA Jyothsna, BENADE Vijay Sidram, SUBRAMANIAN Ramkumar, JAYARAJAN Pradeep, GOYAL Vinod Kumar
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention provides a method for treating behavioral and psychological symptoms in patient with dementia comprising administering an effective dose of pure 5-HT6 receptor antagonist, masupirdine or a pharmaceutically acceptable salt thereof either alone or in combination with an acetylcholinesterase inhibitor such as donepezil and NMDA (N-Methyl-D-aspartate) receptor antagonist, memantine. The present invention further provides use of the said compound in the manufacture of a medicament and pharmaceutical compositions comprising the said compounds intended for the treatment of the disorders described herein. La presente invención proporciona un método para tratar síntomas de comportamiento y psicológicos en paciente con demencia que comprende administrar una dosis efectiva de antagonista receptor de 5-HT6 puro, masupiridina o una sal farmacéuticamente aceptable de los mismos ya sea solos o en combinación con inhibidor de acetilcolinesterasa tal como donepezil y antagonista receptor de NMDA (N-Metil-D-aspartato), memantina; la presente invención además proporciona uso de dicho compuesto en la fabricación de un medicamento y composiciones farmacéuticas que comprenden dichos compuestos hechos para el tratamiento de los trastornos aquí descritos.